Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...
Achieves record revenue, GAAP net income1 and adjusted EBITDA2,3 for the fourth quarter and full year 2024Fourth-quarter revenue of $191.5 ...
Thank you for attending today's Highwoods Properties Q4 2024 earnings call. My name is Tamia, and I will be your moderator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback